Published in Am J Hematol on June 05, 2012
Positioning new treatments in the management of immune thrombocytopenia. Pediatr Blood Cancer (2012) 0.82
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol (2012) 0.81
Immune thrombocytopenia. Hematol Oncol Clin North Am (2013) 0.81
Immune thrombocytopenia: getting back to basics. Am J Hematol (2012) 0.79
Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia. Open Med (Wars) (2016) 0.75
International consensus report on the investigation and management of primary immune thrombocytopenia. Blood (2009) 7.72
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood (2011) 6.50
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood (2001) 2.96
Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost (2006) 2.35
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol (2003) 2.28
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol (2010) 1.83
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet (2002) 1.56
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol (2009) 1.56
The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood (1999) 1.55
Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer (2006) 1.21
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol (2008) 1.20
Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol (2009) 1.19
The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol (2009) 1.06
Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J (2007) 1.00
Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey. Curr Med Res Opin (2008) 0.98
Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal. J Thromb Haemost (2008) 0.98
Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol (2004) 0.97
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes (2008) 0.95
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol (2011) 0.93
Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatr (1997) 0.92
Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol (2001) 0.90
Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child (1995) 0.89
Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood (2009) 0.88
Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom. Adv Ther (2011) 0.86
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol (2012) 0.81
Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr (2002) 0.77
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med (2011) 4.76
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med (2013) 4.25
Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA (2013) 4.25
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med (2006) 4.07
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (2008) 3.74
Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood (2009) 3.18
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med (2007) 3.17
Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics (2008) 2.42
Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med (2008) 2.31
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest (2004) 2.30
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood (2008) 2.17
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood (2008) 2.13
Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program (2004) 1.94
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care (2010) 1.88
Parental communication and youth sexual behaviour. J Adolesc (2006) 1.87
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica (2007) 1.87
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion (2004) 1.84
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol (2010) 1.83
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood (2010) 1.76
A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc (2009) 1.70
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med (2004) 1.69
Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy. J Pediatr Hematol Oncol (2002) 1.65
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med (2003) 1.65
Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol (2006) 1.61
Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol (2011) 1.59
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol (2009) 1.56
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf (2009) 1.52
Accuracy of CT in the diagnosis of pulmonary embolism: a systematic literature review. AJR Am J Roentgenol (2004) 1.51
Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol (2003) 1.50
Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med (2006) 1.50
Impact of bariatric surgery on health care utilization and costs among patients with diabetes. Med Care (2012) 1.49
Older patients with diverticulitis have low recurrence rates and rarely need surgery. Surgery (2011) 1.48
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med (2016) 1.47
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood (2014) 1.47
Validating the adapted Diabetes Complications Severity Index in claims data. Am J Manag Care (2012) 1.47
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. Pharmacoeconomics (2010) 1.46
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist (2007) 1.45
Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A. Am J Hematol (2010) 1.40
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica (2007) 1.39
Management of immune thrombocytopenia--something old, something new. N Engl J Med (2010) 1.39
The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract (2004) 1.34
Relationships among youth assets and neighborhood and community resources. Health Educ Behav (2005) 1.28
Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. J Cardiovasc Electrophysiol (2002) 1.27
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion (2012) 1.27
Tobacco use among American Indians in Oklahoma: an epidemiologic view. Public Health Rep (2005) 1.26
Syndromes of thrombotic microangiopathy. N Engl J Med (2014) 1.25
Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev (2013) 1.20
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion (2007) 1.19
Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg (2010) 1.19
A comparison of active adverse event surveillance systems worldwide. Drug Saf (2014) 1.19
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum (2012) 1.19
Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol (2010) 1.18
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer (2013) 1.16
Venous thromboembolism in patients with HIV/AIDS: a case-control study. J Acquir Immune Defic Syndr (2008) 1.14
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion (2006) 1.14
The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol (2007) 1.13
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood (2013) 1.13
Reliability and validity of the youth asset survey (YAS). J Adolesc Health (2002) 1.12
Building capacity to address tobacco-related disparities among American Indian and Hispanic/Latino communities: conceptual and systemic considerations. Addiction (2007) 1.12
Faculty involvement in translational research and interdisciplinary collaboration at a US academic medical center. J Investig Med (2010) 1.11
Hydroxyurea for the treatment of sickle cell disease. Evid Rep Technol Assess (Full Rep) (2008) 1.11
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol (2011) 1.10
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol (2004) 1.09
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion (2009) 1.09
Does participation in a nurse visitation programme reduce the frequency of adverse perinatal outcomes in first-time mothers? Paediatr Perinat Epidemiol (2005) 1.08
Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol (2010) 1.08
Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics (2013) 1.07
Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries. J Gen Intern Med (2014) 1.07
Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Med Care (2013) 1.06
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol (2006) 1.03
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med (2007) 1.03
Effect of childhood obesity prevention programs on blood pressure: a systematic review and meta-analysis. Circulation (2014) 1.02